US5849263A
(en)
*
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
US5576311A
(en)
*
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
US5976573A
(en)
*
|
1996-07-03 |
1999-11-02 |
Rorer Pharmaceutical Products Inc. |
Aqueous-based pharmaceutical composition
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
US5955097A
(en)
*
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
TW503113B
(en)
*
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
KR100508227B1
(ko)
*
|
1997-03-14 |
2006-03-23 |
센주 세이야꾸 가부시키가이샤 |
로테프레드놀에타보네이트수성현탁액
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
SE9704186D0
(sv)
*
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
EP1050299A4
(en)
*
|
1998-01-22 |
2007-05-02 |
Santen Pharmaceutical Co Ltd |
SUSPENSION COLLYRE OF FLUOROMETHOLONE
|
US6103266A
(en)
*
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
AU757896B2
(en)
*
|
1998-09-02 |
2003-03-13 |
Allergan, Inc. |
Preserved cyclodextrin-containing compositions
|
US6395746B1
(en)
|
1998-09-30 |
2002-05-28 |
Alcon Manufacturing, Ltd. |
Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
|
US6716830B2
(en)
|
1998-09-30 |
2004-04-06 |
Alcon, Inc. |
Ophthalmic antibiotic compositions containing moxifloxacin
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
PT1194145E
(pt)
*
|
1999-06-22 |
2003-06-30 |
Boehringer Ingelheim Int |
Solucao estavel de xilometazolina e de oximetazolina
|
FR2796553B1
(fr)
*
|
1999-07-22 |
2001-09-28 |
Warner Lambert Co |
Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant
|
JP2003510263A
(ja)
|
1999-09-24 |
2003-03-18 |
アルコン,インコーポレイテッド |
シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
|
AR026073A1
(es)
|
1999-10-20 |
2002-12-26 |
Nycomed Gmbh |
Composicion farmaceutica acuosa que contiene ciclesonida
|
WO2001028517A1
(fr)
*
|
1999-10-20 |
2001-04-26 |
Teijin Limited |
Compositions therapeutiques aqueuses
|
CN1376066A
(zh)
*
|
1999-11-18 |
2002-10-23 |
爱尔康公司 |
H1拮抗剂和安全类固醇的治疗眼病的用途
|
US20040097486A1
(en)
*
|
1999-11-18 |
2004-05-20 |
Yanni John M. |
Use of an H1 antagonist and a safe steroid to treat eye conditions
|
EP1282401A2
(en)
*
|
2000-05-15 |
2003-02-12 |
PHARMACIA & UPJOHN S.p.A. |
Stabilized steroidal suspension
|
US6495534B2
(en)
*
|
2000-05-15 |
2002-12-17 |
Pharmacia & Upjohn Spa |
Stabilized aqueous suspensions for parenteral use
|
US6462033B2
(en)
|
2000-07-26 |
2002-10-08 |
Alcon Universal Ltd. |
Process for manufacturing compositions containing ciprofloxacin and hydrocortisone
|
BR0115415A
(pt)
*
|
2000-11-15 |
2003-09-09 |
Mohan A Chandavarkar |
Droga de combinação
|
CA2428799A1
(en)
*
|
2000-11-16 |
2002-05-23 |
Alcon Manufacturing, Ltd. |
Combination therapy for lowering and controlling intraocular pressure
|
JP2005504804A
(ja)
*
|
2001-09-21 |
2005-02-17 |
アルコン,インコーポレイテッド |
中耳感染を処置する方法
|
US7001615B1
(en)
|
2001-12-07 |
2006-02-21 |
Alcon, Inc. |
Sustained release ophthalmic, otic and nasal suspension
|
US20090215735A1
(en)
*
|
2002-02-25 |
2009-08-27 |
Alcon, Inc. |
Topical solution formulations containing a corticosteroid and a cyclodextrin
|
WO2004006957A1
(en)
*
|
2002-07-15 |
2004-01-22 |
Alcon, Inc. |
Pharmaceutical compositions for otic use
|
PT1551417E
(pt)
*
|
2002-10-18 |
2008-10-31 |
Aqueous Pharma Ltd |
Formulação de lágrimas com três camadas
|
CA2510296A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
JP4500261B2
(ja)
*
|
2003-01-21 |
2010-07-14 |
千寿製薬株式会社 |
2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性液剤
|
US20050069590A1
(en)
*
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
US20050197303A1
(en)
*
|
2003-10-31 |
2005-09-08 |
Bausch & Lomb Incorporated |
Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
|
US20050095205A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Ramesh Krishnamoorthy |
Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
|
AU2004285592B2
(en)
*
|
2003-11-03 |
2010-02-18 |
Norton Healthcare, Ltd. |
Soft steroid compositions for use in dry powder inhalers
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
JP4820648B2
(ja)
*
|
2003-12-02 |
2011-11-24 |
千寿製薬株式会社 |
ロテプレドノールエタボネート水性懸濁液剤
|
PE20050941A1
(es)
|
2003-12-16 |
2005-11-08 |
Nycomed Gmbh |
Suspensiones acuosas de ciclesonida para nebulizacion
|
AU2005209201B2
(en)
*
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
EP1713514B1
(en)
*
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
US20050182039A1
(en)
*
|
2004-02-13 |
2005-08-18 |
Bausch & Lomb Incorporated |
Use of Loteprednol etabonate for the treatment of dry eye
|
DE602005016392D1
(de)
*
|
2004-03-25 |
2009-10-15 |
Bausch & Lomb |
Verwendung von loteprednoletabonat zur behanldung von trockenen augen
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
EP1773350B1
(en)
*
|
2004-07-12 |
2013-05-29 |
Allergan, Inc. |
Opthalmic compositions for treating ophthalmic conditions
|
CA2580659C
(en)
*
|
2004-09-15 |
2013-02-26 |
Ivx Animal Health, Inc. |
Corticosteroid having low systemic absorption
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
KR20080011310A
(ko)
*
|
2005-05-10 |
2008-02-01 |
알콘, 인코퍼레이티드 |
폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도
|
SI1906916T1
(sl)
*
|
2005-05-10 |
2009-02-28 |
Alcon Inc |
Oftalmična suspenzija, ki obsega oftalmično zdravilo, poloksamin in glikolno sredstvo za naravnavo toničnosti, uporaba sestavka za pripravo zdravila za zdravljenje oftalmičnih motenj
|
US20080269187A1
(en)
*
|
2005-09-26 |
2008-10-30 |
Campbell William R |
Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear
|
EA200800950A1
(ru)
*
|
2005-09-26 |
2008-08-29 |
ПЬЕДМОН ФАРМАСЬЮТИКАЛЗ ЭлЭлСи |
Способы лечения и профилактики среднего отита с применением неионных поверхностно-активных веществ для облегчения трансмембранного введения лекарственного средства в среднее ухо
|
US20090082321A1
(en)
*
|
2007-09-21 |
2009-03-26 |
Allergan, Inc. |
Steroid containing drug delivery systems
|
KR101430760B1
(ko)
|
2005-10-18 |
2014-08-19 |
알러간, 인코포레이티드 |
후안부 조직으로 선택적으로 침투하는 글루코코르티코이드유도체를 사용한 안과 요법
|
US20070093461A1
(en)
*
|
2005-10-26 |
2007-04-26 |
Bausch & Lomb Incorporated |
Effect of Loteprednol etabonate on vascular dysfunction
|
US20070110812A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Bausch & Lomb Incorporated |
Ophthalmic composition for dry eye therapy
|
US20070128251A1
(en)
*
|
2005-12-07 |
2007-06-07 |
Piedmont Pharmaceuticals, Inc. |
Process for manufacturing chewable dosage forms for drug delivery and products thereof
|
US7955632B2
(en)
*
|
2005-12-07 |
2011-06-07 |
Bayer B.V. |
Process for manufacturing chewable dosage forms for drug delivery and products thereof
|
US20070232567A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Curtis Wright |
Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
|
CN102846585A
(zh)
|
2006-03-28 |
2013-01-02 |
杰佛林制药公司 |
低剂量的双氯芬酸和β-环糊精的制剂
|
US20070238789A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Chin-Ming Chang |
Prednisolone acetate compositions
|
WO2008002118A1
(es)
*
|
2006-06-27 |
2008-01-03 |
Arturo Jimenez Bayardo |
Una formulación oftálmica en suspensión de etabonato de loteprednol y clorhidrato de ciprofloxacina
|
MX2009000745A
(es)
|
2006-07-21 |
2009-04-16 |
Biodelivery Sciences Int Inc |
Dispositivos de suministro transmucosa con admision mejorada.
|
WO2008027341A2
(en)
*
|
2006-08-30 |
2008-03-06 |
Merck & Co., Inc. |
Topical ophthalmic formulations
|
WO2008027340A2
(en)
*
|
2006-08-30 |
2008-03-06 |
Merck & Co., Inc. |
Topical ophthalmic formulations
|
CA2663003C
(en)
*
|
2006-09-08 |
2018-02-13 |
Justin Hanes |
Compositions and methods for enhancing transport through mucus
|
TWI415629B
(zh)
|
2006-10-26 |
2013-11-21 |
Otsuka Pharma Co Ltd |
含有瑞巴匹特之水性醫藥懸浮物及其製造方法
|
US20080119448A1
(en)
*
|
2006-11-02 |
2008-05-22 |
Friedlaender Mitchell H |
Methods of treating an ocular allergy with low dose dexamethasone
|
WO2008057364A1
(en)
*
|
2006-11-02 |
2008-05-15 |
Riolan Technologies, Inc. |
Method for treating blepharitis
|
CN101721714B
(zh)
*
|
2009-12-18 |
2011-12-07 |
重庆莱美药业股份有限公司 |
实体瘤被动靶向性抗癌前药及其制备方法
|
WO2011106702A2
(en)
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
JP2014512387A
(ja)
*
|
2011-04-22 |
2014-05-22 |
アルコン リサーチ, リミテッド |
二つの異なる粘性増強剤を有する粘性増強システムを備えた眼科用組成物
|
SG10201610097WA
(en)
|
2011-08-18 |
2017-01-27 |
Biodelivery Sciences Int Inc |
Abuse-resistant mucoadhesive devices for delivery of buprenorphine
|
AU2012312816A1
(en)
|
2011-09-22 |
2014-04-24 |
Bausch & Lomb Incorporated |
Ophthalmic gel compositions
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
CA2867381C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
CN104394891B
(zh)
|
2012-03-16 |
2019-04-16 |
约翰霍普金斯大学 |
用于递送活性剂的非线性多嵌段共聚物-药物结合物
|
NZ742004A
(en)
*
|
2012-05-03 |
2019-04-26 |
Kala Pharmaceuticals Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
EP3808339A1
(en)
|
2012-05-03 |
2021-04-21 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
KR102140989B1
(ko)
|
2012-05-03 |
2020-08-04 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US9889208B2
(en)
|
2012-05-04 |
2018-02-13 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
CN103565740A
(zh)
*
|
2012-07-25 |
2014-02-12 |
天津金耀集团有限公司 |
依碳氯替泼诺混悬滴眼液
|
CN103565742A
(zh)
*
|
2012-07-25 |
2014-02-12 |
天津金耀集团有限公司 |
氟米龙滴眼液
|
WO2014124006A1
(en)
|
2013-02-05 |
2014-08-14 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
JP6669499B2
(ja)
|
2013-02-15 |
2020-03-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
治療用化合物
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
US9353123B2
(en)
|
2013-02-20 |
2016-05-31 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
US20150164882A1
(en)
|
2013-07-22 |
2015-06-18 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
|
US20160279055A1
(en)
|
2013-07-22 |
2016-09-29 |
Imprimis Pharmaceuticals, Inc. |
Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
|
CN106061261B
(zh)
|
2013-11-01 |
2018-04-24 |
卡拉制药公司 |
治疗化合物的结晶形式及其用途
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US10758554B2
(en)
*
|
2014-11-07 |
2020-09-01 |
Santen Pharmaceutical Co., Ltd. |
Ophthalmic aqueous composition
|
JP6846351B2
(ja)
|
2015-01-27 |
2021-03-24 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘膜表面における活性薬剤の増強された輸送のための低張ヒドロゲル製剤
|
CN106279325A
(zh)
*
|
2015-05-27 |
2017-01-04 |
天津金耀集团有限公司 |
一种依碳氯替泼诺新晶型及其制备方法
|
CN106279324A
(zh)
*
|
2015-05-27 |
2017-01-04 |
天津金耀集团有限公司 |
依碳氯替泼诺一水合物及其晶型与制备方法
|
CN106892953A
(zh)
*
|
2015-12-21 |
2017-06-27 |
天津金耀集团有限公司 |
依碳氯替泼诺一水合物及其晶型与制备方法
|
CN106892952A
(zh)
*
|
2015-12-21 |
2017-06-27 |
天津金耀集团有限公司 |
一种依碳氯替泼诺新晶型及其制备方法
|
US10253036B2
(en)
|
2016-09-08 |
2019-04-09 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
EP3509421A4
(en)
|
2016-09-08 |
2020-05-20 |
Kala Pharmaceuticals, Inc. |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF
|
AU2017324716B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US12023344B2
(en)
|
2022-05-25 |
2024-07-02 |
Famygen Life Sciences, Inc. |
Topical otic, ophthalmic, and nasal corticosteroid formulations
|